LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Merck Serono S.A.
Headquarters:
Geneva, GE, Switzerland
Website:
N/A
Year Founded:
1906
Status:
Acquired
BioCentury
|
Jul 18, 2023
Management Tracks
Ballinger at the helm at Lyndra
Plus: Bryan Stuart to lead Atavistik and updates from EnteroBiotix, PTC, CureVac, CytomX, ProKidney and more
Read More
BioCentury
|
Feb 22, 2019
Financial News
Merck KGaA spinout Calypso raises first tranche of €20M series A
Read More
BioCentury
|
Feb 21, 2019
Financial News
Merck KGaA spinout Calypso raises first tranche of €20M series A
Read More
BioCentury
|
Mar 23, 2018
Company News
Lundbeck snags PD play Prexton
Read More
BioCentury
|
Mar 16, 2018
Company News
Lundbeck snags PD play Prexton
Read More
BioCentury
|
Dec 9, 2017
Strategy
Genmab’s second act
Why Genmab thinks the time is right to build a commercial organization
Read More
BioCentury
|
Feb 7, 2017
Financial News
Prexton raises EUR 29M in series B round
Read More
BioCentury
|
Nov 16, 2015
Clinical News
BeiGene-290: Phase I data
Read More
BioCentury
|
Nov 12, 2015
Distillery Techniques
Techniques: Tool compounds for probing cyclin dependent kinase 8 (CDK8)- and cyclin dependent kinase 19 (CDK19; CDC2L6)-dependent tumor growth
Read More
BioCentury
|
Oct 5, 2015
Company News
BioMarin, Serono deal
Read More
Items per page:
10
1 - 10 of 379
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help